Literature DB >> 17667776

Management of acoustic neuromas in patients 65 years or older.

Pamela C Roehm1, Bruce J Gantz.   

Abstract

OBJECTIVE: To analyze an optimal management protocol for patients 65 years or older at the time of acoustic neuroma diagnosis. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary care hospital. PATIENTS: Two hundred sixteen patients with acoustic neuroma 65 years or older at time of diagnosis. INTERVENTION: Patients with smaller tumors (<2.5 cm) were followed with serial magnetic resonance imaging. If significant growth occurred, they were treated with surgery. Surgery was performed at initial diagnosis on patients with larger tumors or in selected patients for hearing preservation. Stereotactic radiotherapy was performed for poor surgical candidates and for patient choice. OUTCOME MEASURES: Measurement of acoustic neuroma growth and tabulation of complications.
RESULTS: One hundred fourteen patients were initially managed by observation, 80 with surgery, and 3 with radiation therapy, with an average follow-up of 35.4 months. For patients in the observation group, average tumor growth was 1.2 mm/yr. Thirty-two patients required crossover to surgery or radiotherapy due to tumor growth (average growth, 4.1 versus 0.3 mm/yr for those remaining in the observation group). One of the patients in the observation group had a complication (0.9%).
CONCLUSION: Management of acoustic neuromas in elderly patients can be based on size and "biological age" criteria. Surgical treatment can safely be reserved for the few patients who have significant tumor growth.

Entities:  

Mesh:

Year:  2007        PMID: 17667776     DOI: 10.1097/01.mao.0000281805.44197.ec

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  10 in total

1.  Systematic Review of Hearing Preservation in Observed Vestibular Schwannoma.

Authors:  Martin Reznitsky; Per Cayé-Thomasen
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-01

2.  Long-term hearing preservation after microsurgical excision of vestibular schwannoma.

Authors:  Erika Ann Woodson; Ryan Douglas Dempewolf; Samuel Paul Gubbels; Aaron Thomas Porter; Jacob Jay Oleson; Marlan Rex Hansen; Bruce Jay Gantz
Journal:  Otol Neurotol       Date:  2010-09       Impact factor: 2.311

3.  [Vestibular schwannoma. Part 2: therapy, prognosis, and rehabilitation].

Authors:  W Maier; F Hassepaß; A Aschendorff; R Laszig
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

Review 4.  [Value of different strategies in the treatment of vestibular schwannoma: therapeutic aspects and literature analysis].

Authors:  W Maier; T D Grauvogel; R Laszig; G J Ridder
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

5.  Surgical management of vestibular schwannoma in elderly patients.

Authors:  Amjad Nuseir; Giuliano Sequino; Giuseppe De Donato; Abdelkader Taibah; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-24       Impact factor: 2.503

6.  The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.

Authors:  J Jason Clark; Matthew Provenzano; Henry R Diggelmann; Ningyong Xu; Skylar S Hansen; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

7.  Multifactor Influences of Shared Decision-Making in Acoustic Neuroma Treatment.

Authors:  Jason C Nellis; Jeff D Sharon; Seth E Pross; Lisa E Ishii; Masaru Ishii; Jacob K Dey; Howard W Francis
Journal:  Otol Neurotol       Date:  2017-03       Impact factor: 2.311

8.  Management of growing vestibular schwannomas.

Authors:  Gian Gaetano Ferri; Antonio Pirodda; Alberto Rinaldi Ceroni; Antonio Fioravanti; Fabio Calbucci; Giovanni Carlo Modugno
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-08       Impact factor: 2.503

9.  Diagnostic accuracy of the constructive interference in steady state sequence alone for follow-up imaging of vestibular schwannomas.

Authors:  B Ozgen; B Oguz; A Dolgun
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

10.  Depression and ability to work after vestibular schwannoma surgery: a nationwide registry-based matched cohort study on antidepressants, sedatives, and sick leave.

Authors:  Erik Thurin; Petter Förander; Jiri Bartek; Sasha Gulati; Isabelle Rydén; Anja Smits; Göran Hesselager; Øyvind Salvesen; Asgeir Store Jakola
Journal:  Acta Neurochir (Wien)       Date:  2021-05-07       Impact factor: 2.816

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.